Targeting the Membrane-Anchored Serine Protease Testisin With a Novel Engineered Anthrax Toxin Prodrug to Kill Tumor Cells and Reduce Tumor Burden

Oncotarget - United States
doi 10.18632/oncotarget.5214
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Tumor Targeting and Drug Delivery by Anthrax Toxin

Toxins
MutagenesisToxicologyHealth
2016English

Intermolecular Complementation Achieves High-Specificity Tumor Targeting by Anthrax Toxin

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2005English

Matriptase-3 Is a Novel Phylogenetically Preserved Membrane-Anchored Serine Protease With Broad Serpin Reactivity

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2005English

Comparative Toxicity and Efficacy of Engineered Anthrax Lethal Toxin Variants With Broad Anti-Tumor Activities

Toxicology and Applied Pharmacology
ToxicologyPharmacology
2014English

Tumor Targeting: A Highly Efficient Tumor‐Targeting Nanoprobe With a Novel Cell Membrane Permeability Mechanism (Adv. Mater. 12/2019)

Advanced Materials
Mechanics of MaterialsMaterials ScienceNanotechnologyMechanical EngineeringNanoscience
2019English

A Novel Oncolytic Adenovirus Targeting to Telomerase Activity in Tumor Cells With Potent

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

Targeting Non-Viral Vectors to Tumor Cells and the Tumor Microenvironment

BMC Proceedings
BiochemistryMedicineGeneticsMolecular Biology
2010English

EGFR-Targeting Nanobodies Released by Stem Cells Reduce Tumor Growth

Cancer Discovery
Oncology
2012English

Tumor Targeting With Transgenic Endothelial Cells

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy